MINT strategic investment program
“Investing in innovation”
We invest in innovative biotech and healthcare startups around the world
Mint Venture Partners and its subsidiaries - Mint Square (accelerator) and MintVest (venture capital firm) - invest in innovative biotech and healthcare startups across various growth stages globally. This integrated investment model creates and nurtures a robust ecosystem for commercializing breakthrough technologies that address critical global health challenges.
-
DNA- and mRNA-ba
sed therapeutic cancer vaccines for oncology and immunology applications 

-
Novel ADC therapeutics and precision medicine for cancers
#IPO-ed

-
Cardiac telemetry using wearable sensors
#IPO-ed

-
Novel regenerative thereapeutics using organoids
#IPO-ed

-
World's first mobile MRI
#IPO-ed

-
Novel proteomic-ba<x>sed diagnosis of treatable genetic disorders


-
Innovative genome data analytics for infectious disease and cancer of humans and animals


-
Digital solutions to predict and prevent Alzheimer's disease


-
Wearable device to treat motor disorders of Parkinson's disease


-
Novel AI-powered 3D ultrasound to assess fatty liver and cirrhosis


-
A Flagship Pioneering company developing novel drugs


-
AI/AR ba<x>sed imaging guide of surgical procedures


-
Novel NK cell therapeutics for cancer


-
Novel hemostatic agents and would healing agents


-
Drug discovery using organ chips


-
Novel smart farm technology


-
Lab-cultured meat ba<x>sed on algae engineering


-
Pregnancy/parenting app. & rare disease information platform


-
Novel neural stem cell therapeutics for neurologic diseases


-
AI vision-ba<x>sed behavior test platform for animal behavior testing


-
AI drug discovery and development


-
Development of next-generation diagnostics through detecting prion and protein misfolding diseases


-
Anti-cancer drug development using Targeted Protein Degraders (TPDs)

-
Breast cancer detection using AI-powered ultrasound imaging

-
Development of neuropathic treatments and diagnostic systems such as Alzheimer’s disease


-
Diversified pharmaceutical company with divisionsfor novel medicines and complex generics


-
Platelet-ba<x>sed Innovation


Join our startup investment program
Apply